<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d300" origId="Cerivastatin"><sentence id="DrugDDI.d300.s0" origId="s0" text="Immunosuppressive Drugs, Fibric Acid Derivatives, Niacin (Nicotinic Acid, Erythromycin, Azole Antifungals: Skeletal Muscle."><entity charOffset="0-17" id="DrugDDI.d300.s0.e0" origId="s0.p0" text="Immunosuppressive" type="drug"/><entity charOffset="37-48" id="DrugDDI.d300.s0.e1" origId="s0.p1" text="Derivatives" type="drug"/><entity charOffset="50-56" id="DrugDDI.d300.s0.e2" origId="s0.p2" text="Niacin" type="drug"/><entity charOffset="58-72" id="DrugDDI.d300.s0.e3" origId="s0.p4" text="Nicotinic Acid" type="drug"/><entity charOffset="74-86" id="DrugDDI.d300.s0.e4" origId="s0.p5" text="Erythromycin" type="drug"/><entity charOffset="88-105" id="DrugDDI.d300.s0.e5" origId="s0.p6" text="Azole Antifungals" type="drug"/><pair e1="DrugDDI.d300.s0.e0" e2="DrugDDI.d300.s0.e1" id="DrugDDI.d300.s0.p0" interaction="false"/><pair e1="DrugDDI.d300.s0.e0" e2="DrugDDI.d300.s0.e2" id="DrugDDI.d300.s0.p1" interaction="false"/><pair e1="DrugDDI.d300.s0.e0" e2="DrugDDI.d300.s0.e3" id="DrugDDI.d300.s0.p2" interaction="false"/><pair e1="DrugDDI.d300.s0.e0" e2="DrugDDI.d300.s0.e4" id="DrugDDI.d300.s0.p3" interaction="false"/><pair e1="DrugDDI.d300.s0.e0" e2="DrugDDI.d300.s0.e5" id="DrugDDI.d300.s0.p4" interaction="false"/><pair e1="DrugDDI.d300.s0.e1" e2="DrugDDI.d300.s0.e2" id="DrugDDI.d300.s0.p5" interaction="false"/><pair e1="DrugDDI.d300.s0.e1" e2="DrugDDI.d300.s0.e3" id="DrugDDI.d300.s0.p6" interaction="false"/><pair e1="DrugDDI.d300.s0.e1" e2="DrugDDI.d300.s0.e4" id="DrugDDI.d300.s0.p7" interaction="false"/><pair e1="DrugDDI.d300.s0.e1" e2="DrugDDI.d300.s0.e5" id="DrugDDI.d300.s0.p8" interaction="false"/><pair e1="DrugDDI.d300.s0.e2" e2="DrugDDI.d300.s0.e3" id="DrugDDI.d300.s0.p9" interaction="false"/><pair e1="DrugDDI.d300.s0.e2" e2="DrugDDI.d300.s0.e4" id="DrugDDI.d300.s0.p10" interaction="false"/><pair e1="DrugDDI.d300.s0.e2" e2="DrugDDI.d300.s0.e5" id="DrugDDI.d300.s0.p11" interaction="false"/><pair e1="DrugDDI.d300.s0.e3" e2="DrugDDI.d300.s0.e4" id="DrugDDI.d300.s0.p12" interaction="false"/><pair e1="DrugDDI.d300.s0.e3" e2="DrugDDI.d300.s0.e5" id="DrugDDI.d300.s0.p13" interaction="false"/><pair e1="DrugDDI.d300.s0.e4" e2="DrugDDI.d300.s0.e5" id="DrugDDI.d300.s0.p14" interaction="false"/></sentence><sentence id="DrugDDI.d300.s1" origId="s1" text="ANTACID (Magnesium-Aluminum Hydroxide): Cerivastatin plasma concentrations were not affected by co-administration of antacid."><entity charOffset="0-7" id="DrugDDI.d300.s1.e0" origId="s1.p9" text="ANTACID" type="drug"/><entity charOffset="9-38" id="DrugDDI.d300.s1.e1" origId="s1.p11" text="Magnesium-Aluminum Hydroxide" type="drug"/><entity charOffset="40-52" id="DrugDDI.d300.s1.e2" origId="s1.p14" text="Cerivastatin" type="drug"/><entity charOffset="117-124" id="DrugDDI.d300.s1.e3" origId="s1.p19" text="antacid" type="drug"/><pair e1="DrugDDI.d300.s1.e0" e2="DrugDDI.d300.s1.e1" id="DrugDDI.d300.s1.p0" interaction="false"/><pair e1="DrugDDI.d300.s1.e0" e2="DrugDDI.d300.s1.e2" id="DrugDDI.d300.s1.p1" interaction="false"/><pair e1="DrugDDI.d300.s1.e0" e2="DrugDDI.d300.s1.e3" id="DrugDDI.d300.s1.p2" interaction="false"/><pair e1="DrugDDI.d300.s1.e1" e2="DrugDDI.d300.s1.e2" id="DrugDDI.d300.s1.p3" interaction="false"/><pair e1="DrugDDI.d300.s1.e1" e2="DrugDDI.d300.s1.e3" id="DrugDDI.d300.s1.p4" interaction="false"/><pair e1="DrugDDI.d300.s1.e2" e2="DrugDDI.d300.s1.e3" id="DrugDDI.d300.s1.p5" interaction="false"/><negationtags>&lt;xcope&gt;ANTACID (Magnesium-Aluminum Hydroxide): Cerivastatin plasma concentrations were &lt;cue&gt;not&lt;/cue&gt; affected by co-administration of antacid&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d300.s2" origId="s2" text="CIMETlDINE: Cerivastatin plasma concentrations were not affected by co-administration of cimetidine."><entity charOffset="12-24" id="DrugDDI.d300.s2.e0" origId="s2.p22" text="Cerivastatin" type="drug"/><entity charOffset="89-99" id="DrugDDI.d300.s2.e1" origId="s2.p27" text="cimetidine" type="drug"/><pair e1="DrugDDI.d300.s2.e0" e2="DrugDDI.d300.s2.e1" id="DrugDDI.d300.s2.p0" interaction="false"/><negationtags>&lt;xcope&gt;CIMETlDINE: Cerivastatin plasma concentrations were &lt;cue&gt;not&lt;/cue&gt; affected by co-administration of cimetidine&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d300.s3" origId="s3" text="CHOLESTYRAMINE: The influence of the bile-acidsequestering agent cholestyramine on the pharmacokinetits of cerivastatin sodium was evaluated in 12 healthy males in 2 separate randomized crossover studies."><entity charOffset="0-14" id="DrugDDI.d300.s3.e0" origId="s3.p28" text="CHOLESTYRAMINE" type="drug"/><entity charOffset="37-64" id="DrugDDI.d300.s3.e1" origId="s3.p31" text="bile-acidsequestering agent" type="drug"/><entity charOffset="107-126" id="DrugDDI.d300.s3.e2" origId="s3.p33" text="cerivastatin sodium" type="drug"/><pair e1="DrugDDI.d300.s3.e0" e2="DrugDDI.d300.s3.e1" id="DrugDDI.d300.s3.p0" interaction="false"/><pair e1="DrugDDI.d300.s3.e0" e2="DrugDDI.d300.s3.e2" id="DrugDDI.d300.s3.p1" interaction="false"/><pair e1="DrugDDI.d300.s3.e1" e2="DrugDDI.d300.s3.e2" id="DrugDDI.d300.s3.p2" interaction="false"/></sentence><sentence id="DrugDDI.d300.s4" origId="s4" text="In the first study, concomitant administration of 0.2 mg cerivastatin sodium and 12 g cholestyramine resulted in decreases of more than 22% for AUC and 40% for Cmax when compared to dosing cerivastatin sodium alone."><entity charOffset="57-76" id="DrugDDI.d300.s4.e0" origId="s4.p42" text="cerivastatin sodium" type="drug"/><entity charOffset="86-100" id="DrugDDI.d300.s4.e1" origId="s4.p44" text="cholestyramine" type="drug"/><entity charOffset="189-208" id="DrugDDI.d300.s4.e2" origId="s4.p55" text="cerivastatin sodium" type="drug"/><pair e1="DrugDDI.d300.s4.e0" e2="DrugDDI.d300.s4.e1" id="DrugDDI.d300.s4.p0" interaction="true"/><pair e1="DrugDDI.d300.s4.e0" e2="DrugDDI.d300.s4.e2" id="DrugDDI.d300.s4.p1" interaction="false"/><pair e1="DrugDDI.d300.s4.e1" e2="DrugDDI.d300.s4.e2" id="DrugDDI.d300.s4.p2" interaction="false"/></sentence><sentence id="DrugDDI.d300.s5" origId="s5" text="However, in the second study, administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone."><entity charOffset="53-68" id="DrugDDI.d300.s5.e0" origId="s5.p59" text="cholestyramine" type="drug"/><entity charOffset="110-129" id="DrugDDI.d300.s5.e1" origId="s5.p62" text="cerivastatin sodium" type="drug"/><entity charOffset="210-222" id="DrugDDI.d300.s5.e2" origId="s5.p66" text="cerivastatin" type="drug"/><entity charOffset="304-323" id="DrugDDI.d300.s5.e3" origId="s5.p75" text="cerivastatin sodium" type="drug"/><pair e1="DrugDDI.d300.s5.e0" e2="DrugDDI.d300.s5.e1" id="DrugDDI.d300.s5.p0" interaction="true"/><pair e1="DrugDDI.d300.s5.e0" e2="DrugDDI.d300.s5.e2" id="DrugDDI.d300.s5.p1" interaction="false"/><pair e1="DrugDDI.d300.s5.e0" e2="DrugDDI.d300.s5.e3" id="DrugDDI.d300.s5.p2" interaction="false"/><pair e1="DrugDDI.d300.s5.e1" e2="DrugDDI.d300.s5.e2" id="DrugDDI.d300.s5.p3" interaction="false"/><pair e1="DrugDDI.d300.s5.e1" e2="DrugDDI.d300.s5.e3" id="DrugDDI.d300.s5.p4" interaction="false"/><pair e1="DrugDDI.d300.s5.e2" e2="DrugDDI.d300.s5.e3" id="DrugDDI.d300.s5.p5" interaction="false"/></sentence><sentence id="DrugDDI.d300.s6" origId="s6" text="Therefore, it would be expected that a dosing schedule of cerivastatin sodium given at bedtime and cholestyramine given before the evening meal would not result in a significant decrease in the clinical effect of cerivastatin sodium."><entity charOffset="58-77" id="DrugDDI.d300.s6.e0" origId="s6.p82" text="cerivastatin sodium" type="drug"/><entity charOffset="99-113" id="DrugDDI.d300.s6.e1" origId="s6.p86" text="cholestyramine" type="drug"/><entity charOffset="213-232" id="DrugDDI.d300.s6.e2" origId="s6.p94" text="cerivastatin sodium" type="drug"/><pair e1="DrugDDI.d300.s6.e0" e2="DrugDDI.d300.s6.e1" id="DrugDDI.d300.s6.p0" interaction="false"/><pair e1="DrugDDI.d300.s6.e0" e2="DrugDDI.d300.s6.e2" id="DrugDDI.d300.s6.p1" interaction="false"/><pair e1="DrugDDI.d300.s6.e1" e2="DrugDDI.d300.s6.e2" id="DrugDDI.d300.s6.p2" interaction="false"/><negationtags>Therefore, it would be expected that a dosing schedule of cerivastatin sodium given at bedtime and cholestyramine given before the evening meal would &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; result in a significant decrease in the clinical effect of cerivastatin sodium&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d300.s7" origId="s7" text="DIGOXIN: Plasma digoxin levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin sodium."><entity charOffset="0-7" id="DrugDDI.d300.s7.e0" origId="s7.p95" text="DIGOXIN" type="drug"/><entity charOffset="35-42" id="DrugDDI.d300.s7.e1" origId="s7.p99" text="digoxin" type="drug"/><entity charOffset="118-137" id="DrugDDI.d300.s7.e2" origId="s7.p105" text="cerivastatin sodium" type="drug"/><pair e1="DrugDDI.d300.s7.e0" e2="DrugDDI.d300.s7.e1" id="DrugDDI.d300.s7.p0" interaction="false"/><pair e1="DrugDDI.d300.s7.e0" e2="DrugDDI.d300.s7.e2" id="DrugDDI.d300.s7.p1" interaction="false"/><pair e1="DrugDDI.d300.s7.e1" e2="DrugDDI.d300.s7.e2" id="DrugDDI.d300.s7.p2" interaction="false"/><negationtags>&lt;xcope&gt;DIGOXIN: Plasma digoxin levels and digoxin clearance at steady-state were &lt;cue&gt;not&lt;/cue&gt; affected by co-administration of 0.2 mg cerivastatin sodium&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d300.s8" origId="s8" text="Cerivastatin plasma concentrations were also not affected by co-administration of digoxin."><entity charOffset="0-12" id="DrugDDI.d300.s8.e0" origId="s8.p106" text="Cerivastatin" type="drug"/><entity charOffset="82-89" id="DrugDDI.d300.s8.e1" origId="s8.p112" text="digoxin" type="drug"/><pair e1="DrugDDI.d300.s8.e0" e2="DrugDDI.d300.s8.e1" id="DrugDDI.d300.s8.p0" interaction="false"/><negationtags>Cerivastatin plasma concentrations were also &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; affected by co-administration of digoxin&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d300.s9" origId="s9" text="WARFARIN: Co- administration of warfarin and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo."><entity charOffset="0-8" id="DrugDDI.d300.s9.e0" origId="s9.p113" text="WARFARIN" type="drug"/><entity charOffset="32-40" id="DrugDDI.d300.s9.e1" origId="s9.p116" text="warfarin" type="drug"/><entity charOffset="45-57" id="DrugDDI.d300.s9.e2" origId="s9.p118" text="cerivastatin" type="drug"/><entity charOffset="142-152" id="DrugDDI.d300.s9.e3" origId="s9.p127" text="factor VII" type="drug"/><entity charOffset="191-199" id="DrugDDI.d300.s9.e4" origId="s9.p131" text="warfarin" type="drug"/><pair e1="DrugDDI.d300.s9.e0" e2="DrugDDI.d300.s9.e1" id="DrugDDI.d300.s9.p0" interaction="false"/><pair e1="DrugDDI.d300.s9.e0" e2="DrugDDI.d300.s9.e2" id="DrugDDI.d300.s9.p1" interaction="false"/><pair e1="DrugDDI.d300.s9.e0" e2="DrugDDI.d300.s9.e3" id="DrugDDI.d300.s9.p2" interaction="false"/><pair e1="DrugDDI.d300.s9.e0" e2="DrugDDI.d300.s9.e4" id="DrugDDI.d300.s9.p3" interaction="false"/><pair e1="DrugDDI.d300.s9.e1" e2="DrugDDI.d300.s9.e2" id="DrugDDI.d300.s9.p4" interaction="false"/><pair e1="DrugDDI.d300.s9.e1" e2="DrugDDI.d300.s9.e3" id="DrugDDI.d300.s9.p5" interaction="false"/><pair e1="DrugDDI.d300.s9.e1" e2="DrugDDI.d300.s9.e4" id="DrugDDI.d300.s9.p6" interaction="false"/><pair e1="DrugDDI.d300.s9.e2" e2="DrugDDI.d300.s9.e3" id="DrugDDI.d300.s9.p7" interaction="false"/><pair e1="DrugDDI.d300.s9.e2" e2="DrugDDI.d300.s9.e4" id="DrugDDI.d300.s9.p8" interaction="false"/><pair e1="DrugDDI.d300.s9.e3" e2="DrugDDI.d300.s9.e4" id="DrugDDI.d300.s9.p9" interaction="false"/><negationtags>WARFARIN: Co- administration of warfarin and cerivastatin to healthy volunteers did &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d300.s10" origId="s10" text="The AUC and Cmax of both the (R) and (S) isomers of warfarin were unaffected by concurrent dosing of 0.3 mg cerivastatin sodium."><entity charOffset="52-60" id="DrugDDI.d300.s10.e0" origId="s10.p147" text="warfarin" type="drug"/><entity charOffset="108-127" id="DrugDDI.d300.s10.e1" origId="s10.p151" text="cerivastatin sodium" type="drug"/><pair e1="DrugDDI.d300.s10.e0" e2="DrugDDI.d300.s10.e1" id="DrugDDI.d300.s10.p0" interaction="false"/></sentence><sentence id="DrugDDI.d300.s11" origId="s11" text="Co-administration of warfarin and cerivastatin did not alter the pharmacokinetics of cerivastatin sodium."><entity charOffset="21-29" id="DrugDDI.d300.s11.e0" origId="s11.p153" text="warfarin" type="drug"/><entity charOffset="34-46" id="DrugDDI.d300.s11.e1" origId="s11.p155" text="cerivastatin" type="drug"/><entity charOffset="85-104" id="DrugDDI.d300.s11.e2" origId="s11.p160" text="cerivastatin sodium" type="drug"/><pair e1="DrugDDI.d300.s11.e0" e2="DrugDDI.d300.s11.e1" id="DrugDDI.d300.s11.p0" interaction="false"/><pair e1="DrugDDI.d300.s11.e0" e2="DrugDDI.d300.s11.e2" id="DrugDDI.d300.s11.p1" interaction="false"/><pair e1="DrugDDI.d300.s11.e1" e2="DrugDDI.d300.s11.e2" id="DrugDDI.d300.s11.p2" interaction="false"/><negationtags>Co-administration of warfarin and cerivastatin did &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; alter the pharmacokinetics of cerivastatin sodium&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d300.s12" origId="s12" text="ERYTHROMYCIN: In hypercholesterolemic patients, steady-state cerivastatin AUC and Cmax increased approximately 50% and 24% respectively after 10 days with co-administration of erythromycin, a known inhibitor of cytochrome P450 3A4."><entity charOffset="0-12" id="DrugDDI.d300.s12.e0" origId="s12.p161" text="ERYTHROMYCIN" type="drug"/><entity charOffset="61-73" id="DrugDDI.d300.s12.e1" origId="s12.p164" text="cerivastatin" type="drug"/><entity charOffset="176-188" id="DrugDDI.d300.s12.e2" origId="s12.p174" text="erythromycin" type="drug"/><entity charOffset="211-230" id="DrugDDI.d300.s12.e3" origId="s12.p176" text="cytochrome P450 3A4" type="drug"/><pair e1="DrugDDI.d300.s12.e0" e2="DrugDDI.d300.s12.e1" id="DrugDDI.d300.s12.p0" interaction="false"/><pair e1="DrugDDI.d300.s12.e0" e2="DrugDDI.d300.s12.e2" id="DrugDDI.d300.s12.p1" interaction="false"/><pair e1="DrugDDI.d300.s12.e0" e2="DrugDDI.d300.s12.e3" id="DrugDDI.d300.s12.p2" interaction="false"/><pair e1="DrugDDI.d300.s12.e1" e2="DrugDDI.d300.s12.e2" id="DrugDDI.d300.s12.p3" interaction="true"/><pair e1="DrugDDI.d300.s12.e1" e2="DrugDDI.d300.s12.e3" id="DrugDDI.d300.s12.p4" interaction="false"/><pair e1="DrugDDI.d300.s12.e2" e2="DrugDDI.d300.s12.e3" id="DrugDDI.d300.s12.p5" interaction="false"/></sentence><sentence id="DrugDDI.d300.s13" origId="s13" text="OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions."><entity charOffset="106-125" id="DrugDDI.d300.s13.e0" origId="s13.p186" text="cerivastatin sodium" type="drug"/><entity charOffset="154-184" id="DrugDDI.d300.s13.e1" origId="s13.p190" text="angiotensin- converting enzyme" type="drug"/><entity charOffset="217-241" id="DrugDDI.d300.s13.e2" origId="s13.p196" text="calcium-channel blockers" type="drug"/><entity charOffset="243-252" id="DrugDDI.d300.s13.e3" origId="s13.p197" text="diuretics" type="drug"/><entity charOffset="258-294" id="DrugDDI.d300.s13.e4" origId="s13.p199" text="nonsteroidal anti-inflammatory drugs" type="drug"/><entity charOffset="296-302" id="DrugDDI.d300.s13.e5" origId="s13.p201" text="NSAIDs" type="drug"/><pair e1="DrugDDI.d300.s13.e0" e2="DrugDDI.d300.s13.e1" id="DrugDDI.d300.s13.p0" interaction="false"/><pair e1="DrugDDI.d300.s13.e0" e2="DrugDDI.d300.s13.e2" id="DrugDDI.d300.s13.p1" interaction="false"/><pair e1="DrugDDI.d300.s13.e0" e2="DrugDDI.d300.s13.e3" id="DrugDDI.d300.s13.p2" interaction="false"/><pair e1="DrugDDI.d300.s13.e0" e2="DrugDDI.d300.s13.e4" id="DrugDDI.d300.s13.p3" interaction="false"/><pair e1="DrugDDI.d300.s13.e0" e2="DrugDDI.d300.s13.e5" id="DrugDDI.d300.s13.p4" interaction="false"/><pair e1="DrugDDI.d300.s13.e1" e2="DrugDDI.d300.s13.e2" id="DrugDDI.d300.s13.p5" interaction="false"/><pair e1="DrugDDI.d300.s13.e1" e2="DrugDDI.d300.s13.e3" id="DrugDDI.d300.s13.p6" interaction="false"/><pair e1="DrugDDI.d300.s13.e1" e2="DrugDDI.d300.s13.e4" id="DrugDDI.d300.s13.p7" interaction="false"/><pair e1="DrugDDI.d300.s13.e1" e2="DrugDDI.d300.s13.e5" id="DrugDDI.d300.s13.p8" interaction="false"/><pair e1="DrugDDI.d300.s13.e2" e2="DrugDDI.d300.s13.e3" id="DrugDDI.d300.s13.p9" interaction="false"/><pair e1="DrugDDI.d300.s13.e2" e2="DrugDDI.d300.s13.e4" id="DrugDDI.d300.s13.p10" interaction="false"/><pair e1="DrugDDI.d300.s13.e2" e2="DrugDDI.d300.s13.e5" id="DrugDDI.d300.s13.p11" interaction="false"/><pair e1="DrugDDI.d300.s13.e3" e2="DrugDDI.d300.s13.e4" id="DrugDDI.d300.s13.p12" interaction="false"/><pair e1="DrugDDI.d300.s13.e3" e2="DrugDDI.d300.s13.e5" id="DrugDDI.d300.s13.p13" interaction="false"/><pair e1="DrugDDI.d300.s13.e4" e2="DrugDDI.d300.s13.e5" id="DrugDDI.d300.s13.p14" interaction="false"/><negationtags>OTHER CONCOMITANT THERAPY: Although specific interaction studies were &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; performed&lt;/xcope&gt;, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) &lt;xcope&gt;&lt;cue&gt;without&lt;/cue&gt; evidence of clinically significant adverse interactions&lt;/xcope&gt;.</negationtags></sentence></document>